“…Strategies to attenuate the neurological symptoms of acute injury are of great clinical importance and their development is the subject of major research interest (Harvey et al, 2003). Intrastriatal delivery of Bcl-2, GDNF or Hsp72 with HSV-1 based vectors was previously shown to protect a small percentage of neurons from ischemic death (Linnik et al, 1995;Lawrence et al, 1996;Fink et al, 1997;Wang et al, 1997;Yenari et al, 1998;Antonawich et al, 1999;Harvey et al, 2003), but at least one such vector, caused inflammation and neurotoxicity (Monville et al, 2004). Genome-free HSV-based vectors were constructed (amplicons), and their safety improved by the development of a helper-free delivery system that supports the replication and packaging of co-transfected amplicon DNA (Olschowka et al, 2003).…”